Molecular genetic evidence supporting the origin of somatic-type malignancy and teratoma from the same progenitor cell

American Journal of Surgical Pathology

Volumn 36, Issue 12, 2012, Pages 1849-1856

  Kum, Jennifer B ^a   Ulbright, Thomas M ^a   Williamson, Sean R ^a   Wang, Mingsheng ^a   Zhang, Shaobo ^a   Foster, Richard S ^a   Grignon, David J ^a   Eble, John N ^a   Beck, Stephen D W ^a   Cheng, Liang ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

clonal origin; isochromosome 12p; laser capture microdissection; loss of heterozygosity; mixed germ cell tumor; molecular genetics; somatic malignancy secondary malignant component; teratoma; testis

Indexed keywords

FIXATIVE; FORMALDEHYDE; MICROSATELLITE DNA; PARAFFIN;

ADOLESCENT; ADULT; ARTICLE; CANCER STEM CELL; CELL CLONE; CELL LINEAGE; CHROMOSOME 12; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HETEROZYGOSITY LOSS; HUMAN; LASER CAPTURE MICRODISSECTION; MALE; METASTASIS; MIDDLE AGED; MIXED TUMOR; PATHOLOGY; TERATOMA; TESTIS TUMOR; TISSUE FIXATION;

ADOLESCENT; ADULT; CELL LINEAGE; CHROMOSOMES, HUMAN, PAIR 12; CLONE CELLS; FIXATIVES; FORMALDEHYDE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LASER CAPTURE MICRODISSECTION; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASMS, COMPLEX AND MIXED; NEOPLASTIC STEM CELLS; PARAFFIN EMBEDDING; TERATOMA; TESTICULAR NEOPLASMS; TISSUE FIXATION; YOUNG ADULT;

EID: 84870014466     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31826df1ab     Document Type: Article

References (50)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
2. Cheng L, Zhang S, Eble JN, et al. Molecular genetic evidence supporting the neoplastic nature of fibrous stroma in testicular teratoma. Mod Pathol. 2012; [Epub ahead of print].
3. Sandberg AA, Meloni AM, Suijkerbuijk RF. Reviews of chromosome studies in urological tumors. III. Cytogenetics and genes in testicular tumors. J Urol. 1996;155:1531-1556.
4. Gilbert D, Rapley E, Shipley J. Testicular germ cell tumours: predisposition genes and the male germ cell niche. Nat Rev Cancer. 2011;11:278-288.
5. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer. 2005;5:210-222.
6. Looijenga LH. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. J Pathol. 2009;218:146-162.
7. Pienkowska-Grela B, Grygalewicz B, Bregula U. Overrepresentation of the short arm of chromosome 12 in seminoma and nonseminoma groups of testicular germ cell tumors. Cancer Genet Cytogenet. 2002;134:102-108.
8. Samaniego F, Rodriguez E, Houldsworth J, et al. Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification. Genes Chromosomes Cancer. 1990;1:289-300.
9. Rodriguez E, Houldsworth J, Reuter VE, et al. Molecular cytogenetic analysis of i(12p)-negative human male germ cell tumors. Genes Chromosomes Cancer. 1993;8:230-236.
10. Kernek KM, Ulbright TM, Zhang S, et al. Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis. Am J Pathol. 2003;163:2477-2484.
11. Kernek KM, Brunelli M, Ulbright TM, et al. Fluorescence in situ hybridization analysis of chromosome 12p in paraffin-embedded tissue is useful for establishing germ cell origin of metastatic tumors. Mod Pathol. 2004;17:1309-1313.
12. Ulbright TM, Loehrer PJ, Roth LM, et al. The development of nongerm cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer. 1984;54:1824-1833.
13. Ahmed T, Bosl GJ, Hajdu SI. Teratoma with malignant transformation in germ cell tumors in men. Cancer. 1985;56:860-863.
14. Little JS Jr., Foster RS, Ulbright TM, et al. Unusual neoplasms detected in testis cancer patients undergoing post-chemotherapy retroperitoneal lymphadenectomy. J Urol. 1994;152:1144-1149.
15. Michael H, Hull MT, Ulbright TM, et al. Primitive neuroectodermal tumors arising in testicular germ cell neoplasms. Am J Surg Pathol. 1997;21:896-904.
16. Michael H, Hull MT, Foster RS, et al. Nephroblastoma-like tumors in patients with testicular germ cell tumors. Am J Surg Pathol. 1998;22:1107-1114.
17. Motzer RJ, Amsterdam A, Prieto V, et al. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol. 1998;159:133-138.
18. Spiess PE, Pisters LL, Liu P, et al. Malignant transformation of testicular teratoma: a chemoresistant phenotype. Urol Oncol. 2008;26:595-599.
19. Wick MR, Perlman EJ, Strobel P, et al. Germ cell tumors with somatic-type malignancy. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. Lyon: IARC Press; 2004:216-218.
20. Ulbright TM. Testis risk and prognostic factors. The pathologist's perspective. Urol Clin North Am. 1999;26:611-626.
21. Ulbright TM, Clark SA, Einhorn LH. Angiosarcoma associated with germ cell tumors. Hum Pathol. 1985;16:268-272.
22. Malagon HD, Valdez AM, Moran CA, et al. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohisto-chemical study of 46 cases. Am J Surg Pathol. 2007;31:1356-1362.
23. Michael H, Lucia J, Foster RS, et al. The pathology of late recurrence of testicular germ cell tumors. Am J Surg Pathol. 2000;24:257-273.
24. Comiter CV, Kibel AS, Richie JP, et al. Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol. 1998;159:859-863.
25. Donadio AC, Motzer RJ, Bajorin DF, et al. Chemotherapy for teratoma with malignant transformation. J Clin Oncol. 2003;21:4285-4291.
26. Cheng L, Zhang S, Wang M, et al. Molecular genetic evidence supporting the neoplastic nature of stromal cells in'fibrosis' after chemotherapy for testicular germ cell tumours. J Pathol. 2007;213:65-71.
27. Sung MT, Maclennan GT, Lopez-Beltran A, et al. Primary mediastinal seminoma: a comprehensive assessment integrated with histology, immunohistochemistry, and fluorescence in situ hybridization for chromosome 12p abnormalities in 23 cases. Am J Surg Pathol. 2008;32:146-155.
28. Cossu-Rocca P, Zhang S, Roth LM, et al. Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis. Mod Pathol. 2006;19:611-615.
29. Abbosh PH, Zhang S, Maclennan GT, et al. Germ cell origin of testicular carcinoid tumors. Clin Cancer Res. 2008;14:1393-1396.
30. Cheng L, MacLennan GT, Zhang S, et al. Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma. Clin Cancer Res. 2008;14:8087-8093.
31. Cheng L, Zhang S, MacLennan GT, et al. Interphase fluorescence in situ hybridization analysis of chromosome 12p abnormalities is useful for distinguishing epidermoid cysts of the testis from pure mature teratoma. Clin Cancer Res. 2006;12:5668-5672.
32. Brandli DW, Ulbright TM, Foster RS, et al. Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumors is derived from the same progenitor cells as the teratoma. Cancer Res. 2003;63:6063-6068.
33. Jones TD, Wang M, Sung MT, et al. Clonal origin of metastatic testicular teratomas. Clin Cancer Res. 2006;12:5377-5383.
34. Rothe M, Albers P, Wernert N. Loss of heterozygosity, differentiation, and clonality in microdissected male germ cell tumours. J Pathol. 1999;188:389-394.
35. Heidenreich A, Gaddipati JP, Moul JW, et al. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. J Urol. 1998;159:1725-1730.
36. Younger C, Ulbright TM, Zhang S, et al. Molecular evidence supporting the neoplastic nature of some epidermoid cysts of the testis. Arch Pathol Lab Med. 2003;127:858-860.
37. Korski K, Breborowicz D, Filas V, et al. A case of primary testicular germ cell tumor with rhabdomyosarcoma metastases as an example of applying the FISH method to diagnostic pathology. APMIS. 2007;115:1296-1301.
38. Williamson SR, Kum JB, Shah SR, et al. Signet ring cell carcinoma of the testis: clinicopathologic and molecular evidence for germ cell tumor origin-a case report. Am J Surg Pathol. 2012;36:311-315.
39. Idrees MT, Kuhar M, Ulbright TM, et al. Clonal evidence for the progression of a testicular germ cell tumor to angiosarcoma. Hum Pathol. 2010;41:139-144.
40. Ulbright TM, Hattab EM, Zhang S, et al. Primitive neuro-ectodermal tumors in patients with testicular germ cell tumors usually resemble pediatric-type central nervous system embryonal neoplasms and lack chromosome 22 rearrangements. Mod Pathol. 2010;23:972-980.
41. Masera A, Ovcak Z, Mikuz G. Angiosarcoma of the testis. Virchows Arch. 1999;434:351-353.
42. Emerson RE, Ulbright TM, Zhang S, et al. Nephroblastoma arising in a germ cell tumor of testicular origin. Am J Surg Pathol. 2004;28:687-692.
43. Bajorin DF, Motzer RJ, Rodriguez E, et al. Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. J Natl Cancer Inst. 1993;85:60-62.
44. El Mesbahi O, Terrier-Lacombe MJ, Rebischung C, et al. Chemotherapy in patients with teratoma with malignant transformation. Eur Urol. 2007;51:1306-1311.
45. Necchi A, Colecchia M, Nicolai N, et al. Towards the definition of the best management and prognostic factors of teratoma with malignant transformation: a single-institution case series and new proposal. BJU Int. 2011;107:1088-1094.
46. Czaja JT, Ulbright TM. Evidence for the transformation of seminoma to yolk sac tumor, with histogenetic considerations. Am J Clin Pathol. 1992;97:468-477.
47. Faulkner SW, Leigh DA, Oosterhuis JW, et al. Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model. Br J Cancer. 2000;83:729-736.
48. Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18(suppl 2):S61-S79.
49. Michael H, Ulbright TM, Brodhecker CA. The pluripotential nature of the mesenchyme-like component of yolk sac tumor. Arch Pathol Lab Med. 1989;113:1115-1119.
50. Honecker F, Stoop H, Mayer F, et al. Germ cell lineage differentiation in non-seminomatous germ cell tumours. J Pathol. 2006;208:395-400.